| International staging system for multiple myeloma PR Greipp, JS Miguel, BGM Durie, JJ Crowley, B Barlogie, J Bladé, ... Journal of clinical oncology 23 (15), 3412-3420, 2005 | 3700 | 2005 |
| Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report … JJM Van Dongen, AW Langerak, M Brüggemann, PAS Evans, M Hummel, ... Leukemia 17 (12), 2257-2317, 2003 | 3603 | 2003 |
| International uniform response criteria for multiple myeloma BGM Durie, JL Harousseau, JS Miguel, J Blade, B Barlogie, K Anderson, ... Leukemia 20 (9), 1467-1473, 2006 | 3441 | 2006 |
| The global syndemic of obesity, undernutrition, and climate change: the Lancet Commission report BA Swinburn, VI Kraak, S Allender, VJ Atkins, PI Baker, JR Bogard, ... The lancet 393 (10173), 791-846, 2019 | 2649 | 2019 |
| High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma JA Child, GJ Morgan, FE Davies, RG Owen, SE Bell, K Hawkins, J Brown, ... New England Journal of Medicine 348 (19), 1875-1883, 2003 | 2296 | 2003 |
| Revised international staging system for multiple myeloma: a report from International Myeloma Working Group A Palumbo, H Avet-Loiseau, S Oliva, HM Lokhorst, H Goldschmidt, ... Journal of clinical oncology 33 (26), 2863, 2015 | 2143 | 2015 |
| Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma FE Davies, N Raje, T Hideshima, S Lentzsch, G Young, YT Tai, B Lin, ... Blood, The Journal of the American Society of Hematology 98 (1), 210-216, 2001 | 1223 | 2001 |
| International Myeloma Working Group molecular classification of multiple myeloma: spotlight review R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ... Leukemia 23 (12), 2210-2221, 2009 | 1182 | 2009 |
| The genetic architecture of multiple myeloma GJ Morgan, BA Walker, FE Davies Nature Reviews Cancer 12 (5), 335-348, 2012 | 1087 | 2012 |
| International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hájek, ... Leukemia 23 (2), 215-224, 2009 | 1035 | 2009 |
| Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ... Leukemia 22 (2), 414-423, 2008 | 1021 | 2008 |
| Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ... Leukemia 26 (1), 149-157, 2012 | 1007 | 2012 |
| Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults CF Skibola, MT Smith, E Kane, E Roman, S Rollinson, RA Cartwright, ... Proceedings of the National Academy of Sciences 96 (22), 12810-12815, 1999 | 708 | 1999 |
| First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial GJ Morgan, FE Davies, WM Gregory, K Cocks, SE Bell, AJ Szubert, ... The Lancet 376 (9757), 1989-1999, 2010 | 623 | 2010 |
| Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation BGM Durie, RA Kyle, A Belch, W Bensinger, J Blade, M Boccadoro, ... The Hematology Journal 4 (6), 379-398, 2003 | 619 | 2003 |
| Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma BA Walker, EM Boyle, CP Wardell, A Murison, DB Begum, NM Dahir, ... Journal of clinical oncology 33 (33), 3911-3920, 2015 | 617 | 2015 |
| In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation PD Kottaridis, DW Milligan, R Chopra, RK Chakraverty, S Chakrabarti, ... Blood, The Journal of the American Society of Hematology 96 (7), 2419-2425, 2000 | 603 | 2000 |
| Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002—Medical … BM Augustson, G Begum, JA Dunn, NJ Barth, F Davies, G Morgan, ... Journal of clinical oncology 23 (36), 9219-9226, 2005 | 587 | 2005 |
| Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study AC Rawstron, JA Child, RM de Tute, FE Davies, WM Gregory, SE Bell, ... J Clin Oncol 31 (20), 2540-2547, 2013 | 484 | 2013 |
| Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN) A Palumbo, S Bringhen, H Ludwig, MA Dimopoulos, J Bladé, MV Mateos, ... Blood, The Journal of the American Society of Hematology 118 (17), 4519-4529, 2011 | 464 | 2011 |
Brian A WalkerIndiana UniversityVerified email at iu.edu
